Recombinant human insulin-like growth factor-I | |
---|---|
Trade Name | Pv802 |
Orphan Indication | Short-bowel syndrome as a result of resection of the small bowel or as a result of congenital dysfunction of the intestines |
USA Market Approval | USA |
USA Designation Date | 2000-02-16 00:00:00 |
Sponsor | GroPep Pty Ltd.;Gate 11, Victoria Dr., Adelaide SA 5000; |